Blog

Stephanie Saw: Intra-tumoural heterogeneity of PD-L1 expression analysed by EGFR status

Stephanie Saw/X

Mar 5, 2025, 12:30

Stephanie Saw: Intra-tumoural heterogeneity of PD-L1 expression analysed by EGFR status

Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, shared a paper she and her colleagues authored on X:

“Pleased to share our work examining intra-tumoural heterogeneity of PD-L1 expression analysed by EGFR status and agreement between assays in Lung Cancer Journal. My first IASLC young investigator grant and Conquer Cancer Foundation merit award! Thanks to all co-authors.”

EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancer

Authors: Stephanie Saw et al.

Stephanie Saw

Aaron C. Tan Amit Jain Angela Takano Anne James Boon-Hean Ong cancer Craig Joseph Daniel S. W. Tan Darren W.T. Lim Gillianne G.Y. Lai Joe P.S. Yeong Mei-Kim Ang Nwe Oo Hlaing OncoDaily Oncology Quan Sing Ng Ravindran Kanesvaran Siqin Zhou Stephanie P.L. Saw Sze Huey Tan Tony K.H. Lim Wan Ling Tan Yi Lin Teh

Beyond the Red Carpet: Oscar Winners and Nominees Who Fought Cancer

Oncologist Near Me – Lidia Schapira: A Leader in Cancer Care and Medical Education

CancerWorld welcomes their Co-Editors-in-Chief

Dr. Manette Le Grange joins OncoDaily Editorial Board

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma